ISPOR-EU 2025
Nov 9 - 12, 2025 | Glasgow, UK
The agents listed below are currently under investigation. Their safety and efficacy have not been established.
Poster
Development of a Discrete Choice Experiment Survey to Assess Patient Preferences for Treatment of Metastatic Breast CancerD Chandiwana et al.
Poster
Real-World Burden of Illness in Patients With ER+/HER2- ABC Receiving Second-Line Treatment: Interim Results of Longitudinal Health Utility DataP Chakraborti et al.